Literature DB >> 10097244

Androgen effects on bone metabolism: recent progress and controversies.

L C Hofbauer1, S Khosla.   

Abstract

Androgens have beneficial effects on skeletal development and maintenance in women and men. The detection and functional characterization of androgen receptors in bone cells has implicated bone tissue as a potential target tissue for androgens. Gonadal and adrenal androgens directly regulate various aspects of osteoblastic lineage cells, including proliferation, differentiation, mineralization, and gene expression. These effects may differ depending on the stage of differentiation, the number of androgen receptors, and other inherent characteristics (species, site, cell biology) of the osteoblastic cell system. In addition, recent studies have suggested that some of the anabolic and anti-resorptive effects of androgens on bone may be mediated by regulation of autocrine and paracrine factors in the bone microenvironment, including transforming growth factor-beta, insulin-like growth factors (and their binding proteins), and interleukin-6. This review summarizes the recent progress made in our knowledge of androgen receptor action, local androgen metabolism in bone, and direct and indirect effects of gonadal and adrenal androgens as well as androgen receptor antagonists on bone cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10097244     DOI: 10.1530/eje.0.1400271

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  10 in total

Review 1.  Pathogenesis of postmenopausal osteoporosis.

Authors:  L G Raisz
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

Review 2.  Osteoporosis in men.

Authors:  G M Prelevic
Journal:  J R Soc Med       Date:  2001-12       Impact factor: 5.344

Review 3.  Discovery and therapeutic promise of selective androgen receptor modulators.

Authors:  Jiyun Chen; Juhyun Kim; James T Dalton
Journal:  Mol Interv       Date:  2005-06

Review 4.  Management of endocrine disease: Secondary osteoporosis: pathophysiology and management.

Authors:  Faryal Mirza; Ernesto Canalis
Journal:  Eur J Endocrinol       Date:  2015-05-13       Impact factor: 6.664

Review 5.  Therapeutic targeting of the prostate cancer microenvironment.

Authors:  Maria Karlou; Vassiliki Tzelepi; Eleni Efstathiou
Journal:  Nat Rev Urol       Date:  2010-09       Impact factor: 14.432

Review 6.  Unresolved issues in osteoporosis in men.

Authors:  E Seeman
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

7.  Molecular cloning and functional characterization of the canine androgen receptor.

Authors:  B Lu; S L Smock; T A Castleberry; T A Owen
Journal:  Mol Cell Biochem       Date:  2001-10       Impact factor: 3.396

8.  Suppressive function of androgen receptor in bone resorption.

Authors:  Hirotaka Kawano; Takashi Sato; Takashi Yamada; Takahiro Matsumoto; Keisuke Sekine; Tomoyuki Watanabe; Takashi Nakamura; Toru Fukuda; Kimihiro Yoshimura; Tatsuya Yoshizawa; Ken-Ichi Aihara; Yoko Yamamoto; Yuko Nakamichi; Daniel Metzger; Pierre Chambon; Kozo Nakamura; Hiroshi Kawaguchi; Shigeaki Kato
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-18       Impact factor: 11.205

9.  Dihydrotestosterone, a robust promoter of osteoblastic proliferation and differentiation: understanding of time-mannered and dose-dependent control of bone forming cells.

Authors:  Hnin Ei Thu; Isa Naina Mohamed; Zahid Hussain; Ahmad Nazrun Shuid
Journal:  Iran J Basic Med Sci       Date:  2017-08       Impact factor: 2.699

10.  Osteoclasts directly influence castration-resistant prostate cancer cells.

Authors:  Junchi Huang; Eva Freyhult; Robert Buckland; Andreas Josefsson; Jan-Erik Damber; Karin Welén
Journal:  Clin Exp Metastasis       Date:  2022-08-16       Impact factor: 4.510

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.